Previous Close | 13.37 |
Open | 14.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 14.00 - 14.00 |
52 Week Range | 11.08 - 18.00 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | 1.10 |
PE Ratio (TTM) | 3.89 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.67 (4.78%) |
Ex-Dividend Date | May 21, 2024 |
1y Target Est | N/A |
Manulife Financial Corporation ("Manulife") today announced the applicable dividend rates for its Non-cumulative Rate Reset Class 1 Shares Series 15 (the "Series 15 Preferred Shares") (TSX: MFC.PR.L) and Non-cumulative Floating Rate Class 1 Shares Series 16 (the "Series 16 Preferred Shares").
John Hancock, along with its Toronto-based parent company Manulife (NYSE: MFC), today announced a five-year, multimillion-dollar research collaboration with the Massachusetts Institute of Technology (MIT) AgeLab, a multi-disciplinary research institute that works with business, government, and NGOs, leading innovation and research to help improve the quality of life for the aging population and their loved ones. Over the next five years, Manulife/John Hancock and the MIT AgeLab will collaborate
Manulife Investment Management (Manulife IM) announced today that it has launched two new liquid alternative funds: Manulife Alternative Opportunities Fund and Manulife Strategic Income Plus Fund. The funds are managed by Manulife Investment Management's Canadian fixed-income team and global multi-sector fixed-income team, respectively. The teams manage more than CAD$54 billion combined in assets globally.1